http://new.streetinsider.com Latest StreetInsider.com News Articles en-us Copyright 2026, StreetInsider.com rss@streetinsider.com (SI RSS) rss@streetinsider.com (SI RSS) Thu, 10 Sep 2026 17:18:00 -0400 http://blogs.law.harvard.edu/tech/rss http://www.streetinsider.com/images/rss_logo.gif http://new.streetinsider.com 143 28 0 1 2 3 21 22 23 Saturday Sunday http://www.streetinsider.com/SEC+Filings/Form++144++++++++Aardvark+Therapeutics%2C+++++++++++++++++Filed+by%3A+Sun+Nelson/27049419.html si-local-file:///var/storage/secattach/20260910/27049419.html http://www.streetinsider.com/SEC+Filings/Form++144++++++++Aardvark+Therapeutics%2C+++++++++++++++++Filed+by%3A+Sun+Nelson/27049419.html Thu, 10 Sep 2026 17:18:00 -0400 AARD http://www.streetinsider.com/Press+Releases/INVESTOR+ACTION+NOTICE%3A+Moore+Law+PLLC+Encourages+Investors+in+Aardvark+Therapeutics%2C+Inc.+%28AARD%29+to+Contact+Law+Firm/27048228.html <div class="xn-content"> <p><span class="legendSpanClass"><location value="LU/us.ny.nyc" idsrc="xmltag.org" >NEW YORK</location></span>, <span class="legendSpanClass"><chron>Sept. 10, 2026</chron></span> /PRNewswire/ -- <span>Moore Law, PLLC</span>, a shareholder litigation law firm located on <location>Wall Street</location>, is investigating potential claims against the officers and directors of Aardvark Therapeutics, Inc. (NASDAQ: AARD):</p> <div class="PRN_ImbeddedAssetReference" id="DivAssetPlaceHolder1"> <p> <img src="https://mmx.prnewswire.com/media/MS823123/MooreKuehn.jpg?id=OA2942154" title="logo" alt="logo" /> http://www.streetinsider.com/Press+Releases/INVESTOR+ACTION+NOTICE%3A+Moore+Law+PLLC+Encourages+Investors+in+Aardvark+Therapeutics%2C+Inc.+%28AARD%29+to+Contact+Law+Firm/27048228.html Thu, 10 Sep 2026 15:57:00 -0400 AARD http://www.streetinsider.com/PRNewswire/INVESTOR+ACTION+NOTICE%3A+Moore+Law+PLLC+Encourages+Investors+in+Aardvark+Therapeutics%2C+Inc.+%28AARD%29+to+Contact+Law+Firm/27048228.html <div class="xn-content"> <p><span class="legendSpanClass"><location value="LU/us.ny.nyc" idsrc="xmltag.org" >NEW YORK</location></span>, <span class="legendSpanClass"><chron>Sept. 10, 2026</chron></span> /PRNewswire/ -- <span>Moore Law, PLLC</span>, a shareholder litigation law firm located on <location>Wall Street</location>, is investigating potential claims against the officers and directors of Aardvark Therapeutics, Inc. (NASDAQ: AARD):</p> <div class="PRN_ImbeddedAssetReference" id="DivAssetPlaceHolder1"> <p> <img src="https://mmx.prnewswire.com/media/MS823123/MooreKuehn.jpg?id=OA2942154" title="logo" alt="logo" /> http://www.streetinsider.com/PRNewswire/INVESTOR+ACTION+NOTICE%3A+Moore+Law+PLLC+Encourages+Investors+in+Aardvark+Therapeutics%2C+Inc.+%28AARD%29+to+Contact+Law+Firm/27048228.html Thu, 10 Sep 2026 15:57:00 -0400 AARD http://www.streetinsider.com/Press+Releases/Attention+Long-Term+Shareholders+of+Aardvark+Therapeutics%2C+Inc.+%28NASDAQ%3A+AARD%29%3B+Erasca%2C+Inc.+%28NASDAQ%3A+ERAS%29%3B+Hub+Group%2C+Inc.+%28NASDAQ%3A+HUBG%29%3B+and+New+Era+Energy+%26+Digital%2C+Inc.+%28NASDAQ%3A+NUAI%29%3A+Grabar+L/27045605.html <p align="justify">PHILADELPHIA, Sept. 10, 2026 (GLOBE NEWSWIRE) -- </p> <p align="justify"><strong><u>Aardvark Therapeutics, Inc. (NASDAQ: AARD)</u></strong><strong>:</strong></p> <p align="justify"><strong>Grabar Law Office is investigating claims on behalf of Aardvark Therapeutics, Inc. (NASDAQ: AARD) shareholders who purchased shares on or shortly after the Company’s February 13, 2025, initial public offering (IPO) and have continued to hold their shares.</strong></p> <p align="justify"><strong>What is This Investigation About?</strong> The investigation follows the filing of a securities class action against Aardvark and certain of its officers and directors alleging violations of the federal securities laws in connection with statements concerning the safety and prospects http://www.streetinsider.com/Press+Releases/Attention+Long-Term+Shareholders+of+Aardvark+Therapeutics%2C+Inc.+%28NASDAQ%3A+AARD%29%3B+Erasca%2C+Inc.+%28NASDAQ%3A+ERAS%29%3B+Hub+Group%2C+Inc.+%28NASDAQ%3A+HUBG%29%3B+and+New+Era+Energy+%26+Digital%2C+Inc.+%28NASDAQ%3A+NUAI%29%3A+Grabar+L/27045605.html Thu, 10 Sep 2026 08:21:21 -0400 AARD ERAS HUBG NEHC NUAI http://www.streetinsider.com/Press+Releases/Attention+Long-Term+Shareholders+of+Aardvark+Therapeutics%2C+Inc.+%28NASDAQ%3A+AARD%29%3B+Erasca%2C+Inc.+%28NASDAQ%3A+ERAS%29%3B+Hub+Group%2C+Inc.+%28NASDAQ%3A+HUBG%29%3B+and+New+Era+Energy+%26+Digital%2C+Inc.+%28NASDAQ%3A+NUAI%29%3A+Grabar+L/27045605.html <p align="justify">PHILADELPHIA, Sept. 10, 2026 (GLOBE NEWSWIRE) -- </p> <p align="justify"><strong><u>Aardvark Therapeutics, Inc. (NASDAQ: AARD)</u></strong><strong>:</strong></p> <p align="justify"><strong>Grabar Law Office is investigating claims on behalf of Aardvark Therapeutics, Inc. (NASDAQ: AARD) shareholders who purchased shares on or shortly after the Company’s February 13, 2025, initial public offering (IPO) and have continued to hold their shares.</strong></p> <p align="justify"><strong>What is This Investigation About?</strong> The investigation follows the filing of a securities class action against Aardvark and certain of its officers and directors alleging violations of the federal securities laws in connection with statements concerning the safety and prospects http://www.streetinsider.com/Press+Releases/Attention+Long-Term+Shareholders+of+Aardvark+Therapeutics%2C+Inc.+%28NASDAQ%3A+AARD%29%3B+Erasca%2C+Inc.+%28NASDAQ%3A+ERAS%29%3B+Hub+Group%2C+Inc.+%28NASDAQ%3A+HUBG%29%3B+and+New+Era+Energy+%26+Digital%2C+Inc.+%28NASDAQ%3A+NUAI%29%3A+Grabar+L/27045605.html Thu, 10 Sep 2026 08:21:21 -0400 AARD ERAS HUBG NEHC NUAI http://www.streetinsider.com/Press+Releases/Attention+Long-Term+Shareholders+of+Aardvark+Therapeutics%2C+Inc.+%28NASDAQ%3A+AARD%29%3B+Erasca%2C+Inc.+%28NASDAQ%3A+ERAS%29%3B+Hub+Group%2C+Inc.+%28NASDAQ%3A+HUBG%29%3B+and+New+Era+Energy+%26+Digital%2C+Inc.+%28NASDAQ%3A+NUAI%29%3A+Grabar+L/27045605.html <p align="justify">PHILADELPHIA, Sept. 10, 2026 (GLOBE NEWSWIRE) -- </p> <p align="justify"><strong><u>Aardvark Therapeutics, Inc. (NASDAQ: AARD)</u></strong><strong>:</strong></p> <p align="justify"><strong>Grabar Law Office is investigating claims on behalf of Aardvark Therapeutics, Inc. (NASDAQ: AARD) shareholders who purchased shares on or shortly after the Company’s February 13, 2025, initial public offering (IPO) and have continued to hold their shares.</strong></p> <p align="justify"><strong>What is This Investigation About?</strong> The investigation follows the filing of a securities class action against Aardvark and certain of its officers and directors alleging violations of the federal securities laws in connection with statements concerning the safety and prospects http://www.streetinsider.com/Press+Releases/Attention+Long-Term+Shareholders+of+Aardvark+Therapeutics%2C+Inc.+%28NASDAQ%3A+AARD%29%3B+Erasca%2C+Inc.+%28NASDAQ%3A+ERAS%29%3B+Hub+Group%2C+Inc.+%28NASDAQ%3A+HUBG%29%3B+and+New+Era+Energy+%26+Digital%2C+Inc.+%28NASDAQ%3A+NUAI%29%3A+Grabar+L/27045605.html Thu, 10 Sep 2026 08:21:21 -0400 AARD ERAS HUBG NEHC NUAI http://www.streetinsider.com/Press+Releases/Attention+Long-Term+Shareholders+of+Aardvark+Therapeutics%2C+Inc.+%28NASDAQ%3A+AARD%29%3B+Erasca%2C+Inc.+%28NASDAQ%3A+ERAS%29%3B+Hub+Group%2C+Inc.+%28NASDAQ%3A+HUBG%29%3B+and+New+Era+Energy+%26+Digital%2C+Inc.+%28NASDAQ%3A+NUAI%29%3A+Grabar+L/27045605.html <p align="justify">PHILADELPHIA, Sept. 10, 2026 (GLOBE NEWSWIRE) -- </p> <p align="justify"><strong><u>Aardvark Therapeutics, Inc. (NASDAQ: AARD)</u></strong><strong>:</strong></p> <p align="justify"><strong>Grabar Law Office is investigating claims on behalf of Aardvark Therapeutics, Inc. (NASDAQ: AARD) shareholders who purchased shares on or shortly after the Company’s February 13, 2025, initial public offering (IPO) and have continued to hold their shares.</strong></p> <p align="justify"><strong>What is This Investigation About?</strong> The investigation follows the filing of a securities class action against Aardvark and certain of its officers and directors alleging violations of the federal securities laws in connection with statements concerning the safety and prospects http://www.streetinsider.com/Press+Releases/Attention+Long-Term+Shareholders+of+Aardvark+Therapeutics%2C+Inc.+%28NASDAQ%3A+AARD%29%3B+Erasca%2C+Inc.+%28NASDAQ%3A+ERAS%29%3B+Hub+Group%2C+Inc.+%28NASDAQ%3A+HUBG%29%3B+and+New+Era+Energy+%26+Digital%2C+Inc.+%28NASDAQ%3A+NUAI%29%3A+Grabar+L/27045605.html Thu, 10 Sep 2026 08:21:21 -0400 AARD ERAS HUBG NEHC NUAI http://www.streetinsider.com/Press+Releases/Attention+Long-Term+Shareholders+of+Aardvark+Therapeutics%2C+Inc.+%28NASDAQ%3A+AARD%29%3B+Erasca%2C+Inc.+%28NASDAQ%3A+ERAS%29%3B+Hub+Group%2C+Inc.+%28NASDAQ%3A+HUBG%29%3B+and+New+Era+Energy+%26+Digital%2C+Inc.+%28NASDAQ%3A+NUAI%29%3A+Grabar+L/27045605.html <p align="justify">PHILADELPHIA, Sept. 10, 2026 (GLOBE NEWSWIRE) -- </p> <p align="justify"><strong><u>Aardvark Therapeutics, Inc. (NASDAQ: AARD)</u></strong><strong>:</strong></p> <p align="justify"><strong>Grabar Law Office is investigating claims on behalf of Aardvark Therapeutics, Inc. (NASDAQ: AARD) shareholders who purchased shares on or shortly after the Company’s February 13, 2025, initial public offering (IPO) and have continued to hold their shares.</strong></p> <p align="justify"><strong>What is This Investigation About?</strong> The investigation follows the filing of a securities class action against Aardvark and certain of its officers and directors alleging violations of the federal securities laws in connection with statements concerning the safety and prospects http://www.streetinsider.com/Press+Releases/Attention+Long-Term+Shareholders+of+Aardvark+Therapeutics%2C+Inc.+%28NASDAQ%3A+AARD%29%3B+Erasca%2C+Inc.+%28NASDAQ%3A+ERAS%29%3B+Hub+Group%2C+Inc.+%28NASDAQ%3A+HUBG%29%3B+and+New+Era+Energy+%26+Digital%2C+Inc.+%28NASDAQ%3A+NUAI%29%3A+Grabar+L/27045605.html Thu, 10 Sep 2026 08:21:21 -0400 AARD ERAS HUBG NEHC NUAI http://www.streetinsider.com/Globe+Newswire/Attention+Long-Term+Shareholders+of+Aardvark+Therapeutics%2C+Inc.+%28NASDAQ%3A+AARD%29%3B+Erasca%2C+Inc.+%28NASDAQ%3A+ERAS%29%3B+Hub+Group%2C+Inc.+%28NASDAQ%3A+HUBG%29%3B+and+New+Era+Energy+%26+Digital%2C+Inc.+%28NASDAQ%3A+NUAI%29%3A+Grabar+L/27045605.html <p align="justify">PHILADELPHIA, Sept. 10, 2026 (GLOBE NEWSWIRE) -- </p> <p align="justify"><strong><u>Aardvark Therapeutics, Inc. (NASDAQ: AARD)</u></strong><strong>:</strong></p> <p align="justify"><strong>Grabar Law Office is investigating claims on behalf of Aardvark Therapeutics, Inc. (NASDAQ: AARD) shareholders who purchased shares on or shortly after the Company’s February 13, 2025, initial public offering (IPO) and have continued to hold their shares.</strong></p> <p align="justify"><strong>What is This Investigation About?</strong> The investigation follows the filing of a securities class action against Aardvark and certain of its officers and directors alleging violations of the federal securities laws in connection with statements concerning the safety and prospects http://www.streetinsider.com/Globe+Newswire/Attention+Long-Term+Shareholders+of+Aardvark+Therapeutics%2C+Inc.+%28NASDAQ%3A+AARD%29%3B+Erasca%2C+Inc.+%28NASDAQ%3A+ERAS%29%3B+Hub+Group%2C+Inc.+%28NASDAQ%3A+HUBG%29%3B+and+New+Era+Energy+%26+Digital%2C+Inc.+%28NASDAQ%3A+NUAI%29%3A+Grabar+L/27045605.html Thu, 10 Sep 2026 08:21:21 -0400 AARD ERAS HUBG NEHC NUAI http://www.streetinsider.com/Globe+Newswire/Attention+Long-Term+Shareholders+of+Aardvark+Therapeutics%2C+Inc.+%28NASDAQ%3A+AARD%29%3B+Erasca%2C+Inc.+%28NASDAQ%3A+ERAS%29%3B+Hub+Group%2C+Inc.+%28NASDAQ%3A+HUBG%29%3B+and+New+Era+Energy+%26+Digital%2C+Inc.+%28NASDAQ%3A+NUAI%29%3A+Grabar+L/27045605.html <p align="justify">PHILADELPHIA, Sept. 10, 2026 (GLOBE NEWSWIRE) -- </p> <p align="justify"><strong><u>Aardvark Therapeutics, Inc. (NASDAQ: AARD)</u></strong><strong>:</strong></p> <p align="justify"><strong>Grabar Law Office is investigating claims on behalf of Aardvark Therapeutics, Inc. (NASDAQ: AARD) shareholders who purchased shares on or shortly after the Company’s February 13, 2025, initial public offering (IPO) and have continued to hold their shares.</strong></p> <p align="justify"><strong>What is This Investigation About?</strong> The investigation follows the filing of a securities class action against Aardvark and certain of its officers and directors alleging violations of the federal securities laws in connection with statements concerning the safety and prospects http://www.streetinsider.com/Globe+Newswire/Attention+Long-Term+Shareholders+of+Aardvark+Therapeutics%2C+Inc.+%28NASDAQ%3A+AARD%29%3B+Erasca%2C+Inc.+%28NASDAQ%3A+ERAS%29%3B+Hub+Group%2C+Inc.+%28NASDAQ%3A+HUBG%29%3B+and+New+Era+Energy+%26+Digital%2C+Inc.+%28NASDAQ%3A+NUAI%29%3A+Grabar+L/27045605.html Thu, 10 Sep 2026 08:21:21 -0400 AARD ERAS HUBG NEHC NUAI http://www.streetinsider.com/Globe+Newswire/Attention+Long-Term+Shareholders+of+Aardvark+Therapeutics%2C+Inc.+%28NASDAQ%3A+AARD%29%3B+Erasca%2C+Inc.+%28NASDAQ%3A+ERAS%29%3B+Hub+Group%2C+Inc.+%28NASDAQ%3A+HUBG%29%3B+and+New+Era+Energy+%26+Digital%2C+Inc.+%28NASDAQ%3A+NUAI%29%3A+Grabar+L/27045605.html <p align="justify">PHILADELPHIA, Sept. 10, 2026 (GLOBE NEWSWIRE) -- </p> <p align="justify"><strong><u>Aardvark Therapeutics, Inc. (NASDAQ: AARD)</u></strong><strong>:</strong></p> <p align="justify"><strong>Grabar Law Office is investigating claims on behalf of Aardvark Therapeutics, Inc. (NASDAQ: AARD) shareholders who purchased shares on or shortly after the Company’s February 13, 2025, initial public offering (IPO) and have continued to hold their shares.</strong></p> <p align="justify"><strong>What is This Investigation About?</strong> The investigation follows the filing of a securities class action against Aardvark and certain of its officers and directors alleging violations of the federal securities laws in connection with statements concerning the safety and prospects http://www.streetinsider.com/Globe+Newswire/Attention+Long-Term+Shareholders+of+Aardvark+Therapeutics%2C+Inc.+%28NASDAQ%3A+AARD%29%3B+Erasca%2C+Inc.+%28NASDAQ%3A+ERAS%29%3B+Hub+Group%2C+Inc.+%28NASDAQ%3A+HUBG%29%3B+and+New+Era+Energy+%26+Digital%2C+Inc.+%28NASDAQ%3A+NUAI%29%3A+Grabar+L/27045605.html Thu, 10 Sep 2026 08:21:21 -0400 AARD ERAS HUBG NEHC NUAI http://www.streetinsider.com/Globe+Newswire/Attention+Long-Term+Shareholders+of+Aardvark+Therapeutics%2C+Inc.+%28NASDAQ%3A+AARD%29%3B+Erasca%2C+Inc.+%28NASDAQ%3A+ERAS%29%3B+Hub+Group%2C+Inc.+%28NASDAQ%3A+HUBG%29%3B+and+New+Era+Energy+%26+Digital%2C+Inc.+%28NASDAQ%3A+NUAI%29%3A+Grabar+L/27045605.html <p align="justify">PHILADELPHIA, Sept. 10, 2026 (GLOBE NEWSWIRE) -- </p> <p align="justify"><strong><u>Aardvark Therapeutics, Inc. (NASDAQ: AARD)</u></strong><strong>:</strong></p> <p align="justify"><strong>Grabar Law Office is investigating claims on behalf of Aardvark Therapeutics, Inc. (NASDAQ: AARD) shareholders who purchased shares on or shortly after the Company’s February 13, 2025, initial public offering (IPO) and have continued to hold their shares.</strong></p> <p align="justify"><strong>What is This Investigation About?</strong> The investigation follows the filing of a securities class action against Aardvark and certain of its officers and directors alleging violations of the federal securities laws in connection with statements concerning the safety and prospects http://www.streetinsider.com/Globe+Newswire/Attention+Long-Term+Shareholders+of+Aardvark+Therapeutics%2C+Inc.+%28NASDAQ%3A+AARD%29%3B+Erasca%2C+Inc.+%28NASDAQ%3A+ERAS%29%3B+Hub+Group%2C+Inc.+%28NASDAQ%3A+HUBG%29%3B+and+New+Era+Energy+%26+Digital%2C+Inc.+%28NASDAQ%3A+NUAI%29%3A+Grabar+L/27045605.html Thu, 10 Sep 2026 08:21:21 -0400 AARD ERAS HUBG NEHC NUAI http://www.streetinsider.com/Globe+Newswire/Attention+Long-Term+Shareholders+of+Aardvark+Therapeutics%2C+Inc.+%28NASDAQ%3A+AARD%29%3B+Erasca%2C+Inc.+%28NASDAQ%3A+ERAS%29%3B+Hub+Group%2C+Inc.+%28NASDAQ%3A+HUBG%29%3B+and+New+Era+Energy+%26+Digital%2C+Inc.+%28NASDAQ%3A+NUAI%29%3A+Grabar+L/27045605.html <p align="justify">PHILADELPHIA, Sept. 10, 2026 (GLOBE NEWSWIRE) -- </p> <p align="justify"><strong><u>Aardvark Therapeutics, Inc. (NASDAQ: AARD)</u></strong><strong>:</strong></p> <p align="justify"><strong>Grabar Law Office is investigating claims on behalf of Aardvark Therapeutics, Inc. (NASDAQ: AARD) shareholders who purchased shares on or shortly after the Company’s February 13, 2025, initial public offering (IPO) and have continued to hold their shares.</strong></p> <p align="justify"><strong>What is This Investigation About?</strong> The investigation follows the filing of a securities class action against Aardvark and certain of its officers and directors alleging violations of the federal securities laws in connection with statements concerning the safety and prospects http://www.streetinsider.com/Globe+Newswire/Attention+Long-Term+Shareholders+of+Aardvark+Therapeutics%2C+Inc.+%28NASDAQ%3A+AARD%29%3B+Erasca%2C+Inc.+%28NASDAQ%3A+ERAS%29%3B+Hub+Group%2C+Inc.+%28NASDAQ%3A+HUBG%29%3B+and+New+Era+Energy+%26+Digital%2C+Inc.+%28NASDAQ%3A+NUAI%29%3A+Grabar+L/27045605.html Thu, 10 Sep 2026 08:21:21 -0400 AARD ERAS HUBG NEHC NUAI http://www.streetinsider.com/Press+Releases/Important+Notice+to+Long-Term+Shareholders+of+Aardvark+Therapeutics%2C+Inc.+%28NASDAQ%3A+AARD%29%3B+Flotek+Industries%2C+Inc.+%28NYSE%3A+FTK%29%3B+Hub+Group%2C+Inc.+%28NASDAQ%3A+HUBG%29%3B+and+Insulet+Corporation+%28NASDAQ%3A+PODD%29%3A+G/27009337.html <p align="justify">PHILADELPHIA, Sept. 01, 2026 (GLOBE NEWSWIRE) -- </p> <p align="justify"><strong><u>Aardvark Therapeutics, Inc. (NASDAQ: AARD)</u></strong><strong>:</strong></p> <p align="justify"><strong>Grabar Law Office is investigating claims on behalf of Aardvark Therapeutics, Inc. (NASDAQ: AARD) shareholders who purchased shares on or shortly after the Company’s February 13, 2025, initial public offering (IPO) and have continued to hold their shares.</strong></p> <p align="justify"><strong>What is This Investigation About?</strong> The investigation follows the filing of a securities class action against Aardvark and certain of its officers and directors alleging violations of the federal securities laws in connection with statements concerning the safety and prospects http://www.streetinsider.com/Press+Releases/Important+Notice+to+Long-Term+Shareholders+of+Aardvark+Therapeutics%2C+Inc.+%28NASDAQ%3A+AARD%29%3B+Flotek+Industries%2C+Inc.+%28NYSE%3A+FTK%29%3B+Hub+Group%2C+Inc.+%28NASDAQ%3A+HUBG%29%3B+and+Insulet+Corporation+%28NASDAQ%3A+PODD%29%3A+G/27009337.html Tue, 01 Sep 2026 08:24:16 -0400 AARD FTK HUBG PODD http://www.streetinsider.com/Press+Releases/Important+Notice+to+Long-Term+Shareholders+of+Aardvark+Therapeutics%2C+Inc.+%28NASDAQ%3A+AARD%29%3B+Flotek+Industries%2C+Inc.+%28NYSE%3A+FTK%29%3B+Hub+Group%2C+Inc.+%28NASDAQ%3A+HUBG%29%3B+and+Insulet+Corporation+%28NASDAQ%3A+PODD%29%3A+G/27009337.html <p align="justify">PHILADELPHIA, Sept. 01, 2026 (GLOBE NEWSWIRE) -- </p> <p align="justify"><strong><u>Aardvark Therapeutics, Inc. (NASDAQ: AARD)</u></strong><strong>:</strong></p> <p align="justify"><strong>Grabar Law Office is investigating claims on behalf of Aardvark Therapeutics, Inc. (NASDAQ: AARD) shareholders who purchased shares on or shortly after the Company’s February 13, 2025, initial public offering (IPO) and have continued to hold their shares.</strong></p> <p align="justify"><strong>What is This Investigation About?</strong> The investigation follows the filing of a securities class action against Aardvark and certain of its officers and directors alleging violations of the federal securities laws in connection with statements concerning the safety and prospects http://www.streetinsider.com/Press+Releases/Important+Notice+to+Long-Term+Shareholders+of+Aardvark+Therapeutics%2C+Inc.+%28NASDAQ%3A+AARD%29%3B+Flotek+Industries%2C+Inc.+%28NYSE%3A+FTK%29%3B+Hub+Group%2C+Inc.+%28NASDAQ%3A+HUBG%29%3B+and+Insulet+Corporation+%28NASDAQ%3A+PODD%29%3A+G/27009337.html Tue, 01 Sep 2026 08:24:16 -0400 AARD FTK HUBG PODD http://www.streetinsider.com/Press+Releases/Important+Notice+to+Long-Term+Shareholders+of+Aardvark+Therapeutics%2C+Inc.+%28NASDAQ%3A+AARD%29%3B+Flotek+Industries%2C+Inc.+%28NYSE%3A+FTK%29%3B+Hub+Group%2C+Inc.+%28NASDAQ%3A+HUBG%29%3B+and+Insulet+Corporation+%28NASDAQ%3A+PODD%29%3A+G/27009337.html <p align="justify">PHILADELPHIA, Sept. 01, 2026 (GLOBE NEWSWIRE) -- </p> <p align="justify"><strong><u>Aardvark Therapeutics, Inc. (NASDAQ: AARD)</u></strong><strong>:</strong></p> <p align="justify"><strong>Grabar Law Office is investigating claims on behalf of Aardvark Therapeutics, Inc. (NASDAQ: AARD) shareholders who purchased shares on or shortly after the Company’s February 13, 2025, initial public offering (IPO) and have continued to hold their shares.</strong></p> <p align="justify"><strong>What is This Investigation About?</strong> The investigation follows the filing of a securities class action against Aardvark and certain of its officers and directors alleging violations of the federal securities laws in connection with statements concerning the safety and prospects http://www.streetinsider.com/Press+Releases/Important+Notice+to+Long-Term+Shareholders+of+Aardvark+Therapeutics%2C+Inc.+%28NASDAQ%3A+AARD%29%3B+Flotek+Industries%2C+Inc.+%28NYSE%3A+FTK%29%3B+Hub+Group%2C+Inc.+%28NASDAQ%3A+HUBG%29%3B+and+Insulet+Corporation+%28NASDAQ%3A+PODD%29%3A+G/27009337.html Tue, 01 Sep 2026 08:24:16 -0400 AARD FTK HUBG PODD http://www.streetinsider.com/Press+Releases/Important+Notice+to+Long-Term+Shareholders+of+Aardvark+Therapeutics%2C+Inc.+%28NASDAQ%3A+AARD%29%3B+Flotek+Industries%2C+Inc.+%28NYSE%3A+FTK%29%3B+Hub+Group%2C+Inc.+%28NASDAQ%3A+HUBG%29%3B+and+Insulet+Corporation+%28NASDAQ%3A+PODD%29%3A+G/27009337.html <p align="justify">PHILADELPHIA, Sept. 01, 2026 (GLOBE NEWSWIRE) -- </p> <p align="justify"><strong><u>Aardvark Therapeutics, Inc. (NASDAQ: AARD)</u></strong><strong>:</strong></p> <p align="justify"><strong>Grabar Law Office is investigating claims on behalf of Aardvark Therapeutics, Inc. (NASDAQ: AARD) shareholders who purchased shares on or shortly after the Company’s February 13, 2025, initial public offering (IPO) and have continued to hold their shares.</strong></p> <p align="justify"><strong>What is This Investigation About?</strong> The investigation follows the filing of a securities class action against Aardvark and certain of its officers and directors alleging violations of the federal securities laws in connection with statements concerning the safety and prospects http://www.streetinsider.com/Press+Releases/Important+Notice+to+Long-Term+Shareholders+of+Aardvark+Therapeutics%2C+Inc.+%28NASDAQ%3A+AARD%29%3B+Flotek+Industries%2C+Inc.+%28NYSE%3A+FTK%29%3B+Hub+Group%2C+Inc.+%28NASDAQ%3A+HUBG%29%3B+and+Insulet+Corporation+%28NASDAQ%3A+PODD%29%3A+G/27009337.html Tue, 01 Sep 2026 08:24:16 -0400 AARD FTK HUBG PODD http://www.streetinsider.com/Globe+Newswire/Important+Notice+to+Long-Term+Shareholders+of+Aardvark+Therapeutics%2C+Inc.+%28NASDAQ%3A+AARD%29%3B+Flotek+Industries%2C+Inc.+%28NYSE%3A+FTK%29%3B+Hub+Group%2C+Inc.+%28NASDAQ%3A+HUBG%29%3B+and+Insulet+Corporation+%28NASDAQ%3A+PODD%29%3A+G/27009337.html <p align="justify">PHILADELPHIA, Sept. 01, 2026 (GLOBE NEWSWIRE) -- </p> <p align="justify"><strong><u>Aardvark Therapeutics, Inc. (NASDAQ: AARD)</u></strong><strong>:</strong></p> <p align="justify"><strong>Grabar Law Office is investigating claims on behalf of Aardvark Therapeutics, Inc. (NASDAQ: AARD) shareholders who purchased shares on or shortly after the Company’s February 13, 2025, initial public offering (IPO) and have continued to hold their shares.</strong></p> <p align="justify"><strong>What is This Investigation About?</strong> The investigation follows the filing of a securities class action against Aardvark and certain of its officers and directors alleging violations of the federal securities laws in connection with statements concerning the safety and prospects http://www.streetinsider.com/Globe+Newswire/Important+Notice+to+Long-Term+Shareholders+of+Aardvark+Therapeutics%2C+Inc.+%28NASDAQ%3A+AARD%29%3B+Flotek+Industries%2C+Inc.+%28NYSE%3A+FTK%29%3B+Hub+Group%2C+Inc.+%28NASDAQ%3A+HUBG%29%3B+and+Insulet+Corporation+%28NASDAQ%3A+PODD%29%3A+G/27009337.html Tue, 01 Sep 2026 08:24:16 -0400 AARD FTK HUBG PODD http://www.streetinsider.com/Globe+Newswire/Important+Notice+to+Long-Term+Shareholders+of+Aardvark+Therapeutics%2C+Inc.+%28NASDAQ%3A+AARD%29%3B+Flotek+Industries%2C+Inc.+%28NYSE%3A+FTK%29%3B+Hub+Group%2C+Inc.+%28NASDAQ%3A+HUBG%29%3B+and+Insulet+Corporation+%28NASDAQ%3A+PODD%29%3A+G/27009337.html <p align="justify">PHILADELPHIA, Sept. 01, 2026 (GLOBE NEWSWIRE) -- </p> <p align="justify"><strong><u>Aardvark Therapeutics, Inc. (NASDAQ: AARD)</u></strong><strong>:</strong></p> <p align="justify"><strong>Grabar Law Office is investigating claims on behalf of Aardvark Therapeutics, Inc. (NASDAQ: AARD) shareholders who purchased shares on or shortly after the Company’s February 13, 2025, initial public offering (IPO) and have continued to hold their shares.</strong></p> <p align="justify"><strong>What is This Investigation About?</strong> The investigation follows the filing of a securities class action against Aardvark and certain of its officers and directors alleging violations of the federal securities laws in connection with statements concerning the safety and prospects http://www.streetinsider.com/Globe+Newswire/Important+Notice+to+Long-Term+Shareholders+of+Aardvark+Therapeutics%2C+Inc.+%28NASDAQ%3A+AARD%29%3B+Flotek+Industries%2C+Inc.+%28NYSE%3A+FTK%29%3B+Hub+Group%2C+Inc.+%28NASDAQ%3A+HUBG%29%3B+and+Insulet+Corporation+%28NASDAQ%3A+PODD%29%3A+G/27009337.html Tue, 01 Sep 2026 08:24:16 -0400 AARD FTK HUBG PODD http://www.streetinsider.com/Globe+Newswire/Important+Notice+to+Long-Term+Shareholders+of+Aardvark+Therapeutics%2C+Inc.+%28NASDAQ%3A+AARD%29%3B+Flotek+Industries%2C+Inc.+%28NYSE%3A+FTK%29%3B+Hub+Group%2C+Inc.+%28NASDAQ%3A+HUBG%29%3B+and+Insulet+Corporation+%28NASDAQ%3A+PODD%29%3A+G/27009337.html <p align="justify">PHILADELPHIA, Sept. 01, 2026 (GLOBE NEWSWIRE) -- </p> <p align="justify"><strong><u>Aardvark Therapeutics, Inc. (NASDAQ: AARD)</u></strong><strong>:</strong></p> <p align="justify"><strong>Grabar Law Office is investigating claims on behalf of Aardvark Therapeutics, Inc. (NASDAQ: AARD) shareholders who purchased shares on or shortly after the Company’s February 13, 2025, initial public offering (IPO) and have continued to hold their shares.</strong></p> <p align="justify"><strong>What is This Investigation About?</strong> The investigation follows the filing of a securities class action against Aardvark and certain of its officers and directors alleging violations of the federal securities laws in connection with statements concerning the safety and prospects http://www.streetinsider.com/Globe+Newswire/Important+Notice+to+Long-Term+Shareholders+of+Aardvark+Therapeutics%2C+Inc.+%28NASDAQ%3A+AARD%29%3B+Flotek+Industries%2C+Inc.+%28NYSE%3A+FTK%29%3B+Hub+Group%2C+Inc.+%28NASDAQ%3A+HUBG%29%3B+and+Insulet+Corporation+%28NASDAQ%3A+PODD%29%3A+G/27009337.html Tue, 01 Sep 2026 08:24:16 -0400 AARD FTK HUBG PODD http://www.streetinsider.com/Globe+Newswire/Important+Notice+to+Long-Term+Shareholders+of+Aardvark+Therapeutics%2C+Inc.+%28NASDAQ%3A+AARD%29%3B+Flotek+Industries%2C+Inc.+%28NYSE%3A+FTK%29%3B+Hub+Group%2C+Inc.+%28NASDAQ%3A+HUBG%29%3B+and+Insulet+Corporation+%28NASDAQ%3A+PODD%29%3A+G/27009337.html <p align="justify">PHILADELPHIA, Sept. 01, 2026 (GLOBE NEWSWIRE) -- </p> <p align="justify"><strong><u>Aardvark Therapeutics, Inc. (NASDAQ: AARD)</u></strong><strong>:</strong></p> <p align="justify"><strong>Grabar Law Office is investigating claims on behalf of Aardvark Therapeutics, Inc. (NASDAQ: AARD) shareholders who purchased shares on or shortly after the Company’s February 13, 2025, initial public offering (IPO) and have continued to hold their shares.</strong></p> <p align="justify"><strong>What is This Investigation About?</strong> The investigation follows the filing of a securities class action against Aardvark and certain of its officers and directors alleging violations of the federal securities laws in connection with statements concerning the safety and prospects http://www.streetinsider.com/Globe+Newswire/Important+Notice+to+Long-Term+Shareholders+of+Aardvark+Therapeutics%2C+Inc.+%28NASDAQ%3A+AARD%29%3B+Flotek+Industries%2C+Inc.+%28NYSE%3A+FTK%29%3B+Hub+Group%2C+Inc.+%28NASDAQ%3A+HUBG%29%3B+and+Insulet+Corporation+%28NASDAQ%3A+PODD%29%3A+G/27009337.html Tue, 01 Sep 2026 08:24:16 -0400 AARD FTK HUBG PODD http://www.streetinsider.com/Press+Releases/Important+Notice+to+Long-Term+Shareholders+Aardvark+Therapeutics%2C+Inc.+%28NASDAQ%3A+AARD%29%3B+Flotek+Industries%2C+Inc.+%28NYSE%3A+FTK%29%3B+GoDaddy+Inc.+%28NYSE%3A+GDDY%29%3B+and+The+Simply+Good+Foods+Company+%28NASDAQ%3A+SMPL%29%3B/27001662.html <p align="justify">PHILADELPHIA, Aug. 31, 2026 (GLOBE NEWSWIRE) -- </p> <p align="justify"><strong><u>Aardvark Therapeutics, Inc. (NASDAQ: AARD)</u></strong><strong>:</strong></p> <p align="justify"><strong>Grabar Law Office is investigating claims on behalf of Aardvark Therapeutics, Inc. (NASDAQ: AARD) shareholders who purchased shares on or shortly after the Company’s February 13, 2025, initial public offering (IPO) and have continued to hold their shares.</strong></p> <p align="justify"><strong>What is This Investigation About?</strong> The investigation follows the filing of a securities class action against Aardvark and certain of its officers and directors alleging violations of the federal securities laws in connection with statements concerning the safety and prospects http://www.streetinsider.com/Press+Releases/Important+Notice+to+Long-Term+Shareholders+Aardvark+Therapeutics%2C+Inc.+%28NASDAQ%3A+AARD%29%3B+Flotek+Industries%2C+Inc.+%28NYSE%3A+FTK%29%3B+GoDaddy+Inc.+%28NYSE%3A+GDDY%29%3B+and+The+Simply+Good+Foods+Company+%28NASDAQ%3A+SMPL%29%3B/27001662.html Mon, 31 Aug 2026 08:44:25 -0400 AARD AARD AARD AARD FTK FTK FTK FTK FTK GDDY GDDY GDDY GDDY GDDY SMPL SMPL SMPL SMPL SMPL http://www.streetinsider.com/Press+Releases/Important+Notice+to+Long-Term+Shareholders+Aardvark+Therapeutics%2C+Inc.+%28NASDAQ%3A+AARD%29%3B+Flotek+Industries%2C+Inc.+%28NYSE%3A+FTK%29%3B+GoDaddy+Inc.+%28NYSE%3A+GDDY%29%3B+and+The+Simply+Good+Foods+Company+%28NASDAQ%3A+SMPL%29%3B/27001662.html <p align="justify">PHILADELPHIA, Aug. 31, 2026 (GLOBE NEWSWIRE) -- </p> <p align="justify"><strong><u>Aardvark Therapeutics, Inc. (NASDAQ: AARD)</u></strong><strong>:</strong></p> <p align="justify"><strong>Grabar Law Office is investigating claims on behalf of Aardvark Therapeutics, Inc. (NASDAQ: AARD) shareholders who purchased shares on or shortly after the Company’s February 13, 2025, initial public offering (IPO) and have continued to hold their shares.</strong></p> <p align="justify"><strong>What is This Investigation About?</strong> The investigation follows the filing of a securities class action against Aardvark and certain of its officers and directors alleging violations of the federal securities laws in connection with statements concerning the safety and prospects http://www.streetinsider.com/Press+Releases/Important+Notice+to+Long-Term+Shareholders+Aardvark+Therapeutics%2C+Inc.+%28NASDAQ%3A+AARD%29%3B+Flotek+Industries%2C+Inc.+%28NYSE%3A+FTK%29%3B+GoDaddy+Inc.+%28NYSE%3A+GDDY%29%3B+and+The+Simply+Good+Foods+Company+%28NASDAQ%3A+SMPL%29%3B/27001662.html Mon, 31 Aug 2026 08:44:25 -0400 AARD AARD AARD AARD FTK FTK FTK FTK FTK GDDY GDDY GDDY GDDY GDDY SMPL SMPL SMPL SMPL SMPL http://www.streetinsider.com/Press+Releases/Important+Notice+to+Long-Term+Shareholders+Aardvark+Therapeutics%2C+Inc.+%28NASDAQ%3A+AARD%29%3B+Flotek+Industries%2C+Inc.+%28NYSE%3A+FTK%29%3B+GoDaddy+Inc.+%28NYSE%3A+GDDY%29%3B+and+The+Simply+Good+Foods+Company+%28NASDAQ%3A+SMPL%29%3B/27001662.html <p align="justify">PHILADELPHIA, Aug. 31, 2026 (GLOBE NEWSWIRE) -- </p> <p align="justify"><strong><u>Aardvark Therapeutics, Inc. (NASDAQ: AARD)</u></strong><strong>:</strong></p> <p align="justify"><strong>Grabar Law Office is investigating claims on behalf of Aardvark Therapeutics, Inc. (NASDAQ: AARD) shareholders who purchased shares on or shortly after the Company’s February 13, 2025, initial public offering (IPO) and have continued to hold their shares.</strong></p> <p align="justify"><strong>What is This Investigation About?</strong> The investigation follows the filing of a securities class action against Aardvark and certain of its officers and directors alleging violations of the federal securities laws in connection with statements concerning the safety and prospects http://www.streetinsider.com/Press+Releases/Important+Notice+to+Long-Term+Shareholders+Aardvark+Therapeutics%2C+Inc.+%28NASDAQ%3A+AARD%29%3B+Flotek+Industries%2C+Inc.+%28NYSE%3A+FTK%29%3B+GoDaddy+Inc.+%28NYSE%3A+GDDY%29%3B+and+The+Simply+Good+Foods+Company+%28NASDAQ%3A+SMPL%29%3B/27001662.html Mon, 31 Aug 2026 08:44:25 -0400 AARD AARD AARD AARD FTK FTK FTK FTK FTK GDDY GDDY GDDY GDDY GDDY SMPL SMPL SMPL SMPL SMPL http://www.streetinsider.com/Press+Releases/Important+Notice+to+Long-Term+Shareholders+Aardvark+Therapeutics%2C+Inc.+%28NASDAQ%3A+AARD%29%3B+Flotek+Industries%2C+Inc.+%28NYSE%3A+FTK%29%3B+GoDaddy+Inc.+%28NYSE%3A+GDDY%29%3B+and+The+Simply+Good+Foods+Company+%28NASDAQ%3A+SMPL%29%3B/27001662.html <p align="justify">PHILADELPHIA, Aug. 31, 2026 (GLOBE NEWSWIRE) -- </p> <p align="justify"><strong><u>Aardvark Therapeutics, Inc. (NASDAQ: AARD)</u></strong><strong>:</strong></p> <p align="justify"><strong>Grabar Law Office is investigating claims on behalf of Aardvark Therapeutics, Inc. (NASDAQ: AARD) shareholders who purchased shares on or shortly after the Company’s February 13, 2025, initial public offering (IPO) and have continued to hold their shares.</strong></p> <p align="justify"><strong>What is This Investigation About?</strong> The investigation follows the filing of a securities class action against Aardvark and certain of its officers and directors alleging violations of the federal securities laws in connection with statements concerning the safety and prospects http://www.streetinsider.com/Press+Releases/Important+Notice+to+Long-Term+Shareholders+Aardvark+Therapeutics%2C+Inc.+%28NASDAQ%3A+AARD%29%3B+Flotek+Industries%2C+Inc.+%28NYSE%3A+FTK%29%3B+GoDaddy+Inc.+%28NYSE%3A+GDDY%29%3B+and+The+Simply+Good+Foods+Company+%28NASDAQ%3A+SMPL%29%3B/27001662.html Mon, 31 Aug 2026 08:44:25 -0400 AARD AARD AARD AARD FTK FTK FTK FTK FTK GDDY GDDY GDDY GDDY GDDY SMPL SMPL SMPL SMPL SMPL